VIONA PHARMACEUTICALS INC: Drug Recall
Recall #D-0171-2025 · 12/10/2024
Class II: Risk
Recall Details
- Recall Number
- D-0171-2025
- Classification
- Class II
- Product Type
- Drug
- Recalling Firm
- VIONA PHARMACEUTICALS INC
- Status
- Ongoing
- Date Initiated
- 12/10/2024
- Location
- Cranford, NJ, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 23304 packs
Reason for Recall
Crystallization
Product Description
Dapsone Gel 7.5%, 60 g, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Ahemedabad, India, Distributed by: Viona Pharmaceuticals Inc., Cranford, NJ 07016, NDC 72578-094-02. packaged in an Airless pump pack
Distribution Pattern
US Nationwide
Other Recalls by VIONA PHARMACEUTICALS INC
- Class II: Risk 10/06/2025
- Class II: Risk 08/12/2025
- Class II: Risk 12/10/2024
- Class II: Risk 10/29/2024
- Class II: Risk 09/24/2024
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.